A1 Refereed original research article in a scientific journal

An update on clinical proteomics in Alzheimer's research




AuthorsKorolainen MA, Nyman TA, Aittokallio T, Pirttila T

PublisherWILEY-BLACKWELL PUBLISHING, INC

Publication year2010

JournalJournal of Neurochemistry

Journal name in sourceJOURNAL OF NEUROCHEMISTRY

Journal acronymJ NEUROCHEM

Number in series6

Volume112

Issue6

First page 1386

Last page1414

Number of pages29

ISSN0022-3042

DOIhttps://doi.org/10.1111/j.1471-4159.2009.06558.x


Abstract

P>Alzheimer's disease (AD) is a pathologically complex and aetiologically multifactorial dementing disorder affecting millions of people worldwide. The pathological brain changes are assumed to occur decades prior to the onset of clinical symptoms. The diagnosis of early AD remains problematic and is mainly based on clinical and neuropsychological findings after the onset of symptoms. Currently available drugs are able to delay the symptom progression of the disease but not to attenuate the progression of pathological brain changes. Many studies exploring AD proteomes have been conducted as the middle of 1990s as a consequence of recent advances in the development of both gel-based and gel-free proteomics approaches. It is hoped that proteomics can contribute to improving the understanding, diagnosis, and follow-up of the progression of AD. In this review, we summarise the present status of proteome alterations, with emphasis on quantitative approaches, in AD brain, CSF and blood, and their relevance to dementia research.




Last updated on 2024-26-11 at 21:31